WORK Medical Technology Group LTD (WOK) company profile
Close on Nov 17, 2026Market cap $123.49MP/E –Yield –
About WORK Medical Technology
Surgical & Medical Instruments & Apparatus, SIC 3841
WORK Medical Technology Group LTD is an exempted holding company that operates primarily through its operating subsidiaries in China. Through these operating entities, the company engages in the research, development, manufacture, and commercialization of medical equipment and consumables. Its product offerings encompass Class I, Class II, and Class III medical devices, serving healthcare providers, distributors, and medical institutions.
The company maintains its operational footprint in the People's Republic of China, conducting business activities through multiple domestic subsidiaries situated across several regional locations, including Hangzhou, Shanghai, Huangshan, and Hunan. Additionally, it maintains an investment holding subsidiary established in Hong Kong. WORK Medical Technology Group LTD maintains its corporate headquarters and principal executive offices in Hangzhou City, Zhejiang Province, China.
Summary of the business section of WORK Medical Technology's latest annual report, written by StockData.
Company profile
Company
- Legal name
- WORK Medical Technology Group LTD
- Headquarters
- Auckland City, New Zealand
- Address
- 1/88 Cook St 1001
- Phone
- 86-0571-82613568
- Employees
- 46, Sep 30, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- F4
- Fiscal year ends
- September 30
- Auditor
- HTL International, LLC, Houston, Texas
Stock & identifiers
- Ticker
- WOK
- Exchange
- Nasdaq
- IPO date
- Aug 26, 2024
- Shares outstanding
- 104M, Sep 30, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Stock splits
- 1-for-972796 reverse, Aug 14, 2026; 1-for-100 reverse, Jun 18, 2026; 1-for-100 reverse, Dec 29, 2025; 1-for-100 reverse, Oct 21, 2025
- SEC CIK
- 1929783
- CUSIP
- G9767H125
- FIGI
- BBG01GGXSRF7
- Share class FIGI
- BBG01GGXSS83
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Shuang Jarod Wu | CEO and Director | – |
| Baiming Yu | COO and Director | 100,625 |
| Ningfang Liang | Chief Financial Officer | – |
| Robert Brian Johnson | Director | – |
| Qisheng Lin | Director | – |
| Zhenguo Wu | Director | – |
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Aug 26, 2024
- Offer price
- $4.00
- Exchange
- Nasdaq
- First trading day
- Aug 23, 2024
- First-day close
- $3.60-10.0%
- Lock-up ends (est.)
- Feb 19, 2025
“T he initial public offering price of the shares is $4.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“subsidiaries have a sales team of 46 employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jan 31, 2025 | Late filing | Notification of late filing |
| Aug 26, 2024 | IPO | Initial public offering priced (424B4 prospectus) |
| Aug 20, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |
| Jun 23, 2022 | Name change | Name changed from WORK Medical Technology LTD to WORK Medical Technology Group LTD |
See a number that looks wrong?